- Home
- ASND vs ICL Comparison
ASND vs ICL Comparison
Compare ASND & ICL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- ICL
- Stock Information
- Founded
- ASND 2006
- ICL 1968
- Country
- ASND Denmark
- ICL Israel
- Employees
- ASND N/A
- ICL N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- ICL Agricultural Chemicals
- Sector
- ASND Health Care
- ICL Industrials
- Exchange
- ASND Nasdaq
- ICL Nasdaq
- Market Cap
- ASND 9.1B
- ICL 8.1B
- IPO Year
- ASND 2015
- ICL N/A
- Fundamental
- Price
- ASND $157.54
- ICL $6.79
- Analyst Decision
- ASND Strong Buy
- ICL Hold
- Analyst Count
- ASND 16
- ICL 2
- Target Price
- ASND $213.88
- ICL $6.75
- AVG Volume (30 Days)
- ASND 575.6K
- ICL 669.2K
- Earning Date
- ASND 05-01-2025
- ICL 05-19-2025
- Dividend Yield
- ASND N/A
- ICL 2.78%
- EPS Growth
- ASND N/A
- ICL N/A
- EPS
- ASND N/A
- ICL 0.32
- Revenue
- ASND $398,509,511.00
- ICL $6,841,000,000.00
- Revenue This Year
- ASND $72.24
- ICL $4.71
- Revenue Next Year
- ASND $76.59
- ICL $4.08
- P/E Ratio
- ASND N/A
- ICL $21.58
- Revenue Growth
- ASND 12.06
- ICL N/A
- 52 Week Low
- ASND $111.09
- ICL $3.79
- 52 Week High
- ASND $183.00
- ICL $6.84
- Technical
- Relative Strength Index (RSI)
- ASND 48.49
- ICL 61.52
- Support Level
- ASND $151.11
- ICL $6.68
- Resistance Level
- ASND $165.26
- ICL $6.89
- Average True Range (ATR)
- ASND 7.83
- ICL 0.11
- MACD
- ASND -1.28
- ICL -0.02
- Stochastic Oscillator
- ASND 20.71
- ICL 56.88
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About ICL ICL Group Ltd.
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North and South America, and the Rest of the world.